does medicare cover any glp 1 medication covers GLP-1s to treat diabetes and some other health conditions, including obstructive sleep apnea and cardiovascular disease, but not obesity There was a lot of

Both framings are partially true and both get weaponized, just by different industries for different reasons

Abstract Objective Obesity and type 2 diabetes (T2D) are associated with increased rates of mental disorders, particularly depression, anxiety and binge-eating disorder

The Historic WEGOVY Pill Approval On December 22, 2025, the FDA made history

doi: 10.1007/BF01225454

( A , B , D , and E ) Longitudinal data were analyzed by 2-way ANOVA with time and genotype as covariables, idks multiple-comparison test

10,11 Improved Glycaemic Control In addition to their direct effects on the pancreas, GLP-1RAs improve insulin sensitivity in peripheral tissues, like skeletal muscle and the liver